These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 10933669)

  • 21. In vitro activity of cethromycin, a novel antibacterial ketolide, against Chlamydia pneumoniae.
    Miyashita N; Fukano H; Yoshida K; Niki Y; Matsushima T
    J Antimicrob Chemother; 2003 Sep; 52(3):497-9. PubMed ID: 12917246
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The in vitro activity of ABT773, a new ketolide antimicrobial agent.
    Andrews JM; Weller TM; Ashby JP; Walker RM; Wise R
    J Antimicrob Chemother; 2000 Dec; 46(6):1017-22. PubMed ID: 11102425
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NM441: penetration into gynaecological tissues and in vitro activity against clinical isolates from obstetric and gynaecological patients.
    Mikamo H; Kawazoe K; Izumi K; Ito K; Tamaya T
    Drugs; 1995; 49 Suppl 2():326-30. PubMed ID: 8549350
    [No Abstract]   [Full Text] [Related]  

  • 24. [Multicenter study in southern South America of the in vitro activity of telithromycin in strains with defined resistance phenotypes isolated from community-acquired respiratory infections].
    Casellas JM; Visser M; Mac Dougall N; Coco B; Tomé G; Gliosca L;
    Rev Esp Quimioter; 2001 Sep; 14(3):269-74. PubMed ID: 11753448
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evolving resistance patterns in community-acquired respiratory tract pathogens: first results from the PROTEKT global surveillance study. Prospective Resistant Organism Tracking and Epidemiology for the Ketolide Telithromycin.
    Felmingham D
    J Infect; 2002 Feb; 44 Suppl A():3-10. PubMed ID: 12150493
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Microbiological profile of telithromycin, the first ketolide antimicrobial.
    Felmingham D
    Clin Microbiol Infect; 2001; 7 Suppl 3():2-10. PubMed ID: 11523558
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro activities of ketolide HMR 3647, macrolides, and clindamycin against Coryneform bacteria.
    Martínez-Martínez L; Pascual A; Suárez AI; Perea EJ
    Antimicrob Agents Chemother; 1998 Dec; 42(12):3290-2. PubMed ID: 9835530
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and antibacterial activity of novel 2‑fluoro ketolide antibiotics with 11,12‑quinoylalkyl side chains.
    Jin L; Zhang X; Luo Z; Wu X; Zhao Z
    Bioorg Med Chem Lett; 2023 Jan; 80():129115. PubMed ID: 36574853
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anaerobic infections of the female genital tract.
    Thadepalli H
    Scand J Infect Dis Suppl; 1979; (19):80-91. PubMed ID: 379990
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Ketolides and oxazolidinones. Mechanisms of action and antibacterial spectrum].
    Muller-Serieys C
    Presse Med; 2000 Dec; 29(37):2061-4. PubMed ID: 11155736
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of pH on the susceptibility of Helicobacter pylori to the ketolide telithromycin (HMR 3647) and clarithromycin.
    Lascols C; Bryskier A; Soussy CJ; Tanković J
    J Antimicrob Chemother; 2001 Nov; 48(5):738-40. PubMed ID: 11679568
    [No Abstract]   [Full Text] [Related]  

  • 32. In vitro activities of the novel ketolide telithromycin (HMR 3647) against erythromycin-resistant Streptococcus species.
    Jalava J; Kataja J; Seppälä H; Huovinen P
    Antimicrob Agents Chemother; 2001 Mar; 45(3):789-93. PubMed ID: 11181362
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Macrolides, ketolides and streptogramins].
    Mensa J; García-Vázquez E; Vila J
    Enferm Infecc Microbiol Clin; 2003 Apr; 21(4):200-7; quiz 208, 219. PubMed ID: 12681133
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro activity of telithromycin (HMR 3647) against 502 strains of anaerobic bacteria.
    Wexler HM; Molitoris E; Molitoris D; Finegold SM
    J Antimicrob Chemother; 2001 Apr; 47(4):467-9. PubMed ID: 11266423
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In-vitro activity of the new ketolide antibiotic HMR 3647 against gram-positive bacteria.
    Schülin T; Wennersten CB; Moellering RC; Eliopoulos GM
    J Antimicrob Chemother; 1998 Sep; 42(3):297-301. PubMed ID: 9786468
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Molecular analytical evaluation of macrolide- and ketolide-resistant Streptococcus pneumoniae--mechanism of action of telithromycin and resistance to it].
    Inoue M; Kaneko K; Nakano R; Sato Y; Arai S
    Jpn J Antibiot; 2004 Oct; 57(5):425-37. PubMed ID: 15655904
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibacterial effect of telithromycin (HMR 3647) and comparative antibiotics against intracellular Legionella pneumophila.
    Baltch AL; Smith RP; Ritz WJ; Franke MA; Michelsen PB
    J Antimicrob Chemother; 2000 Jul; 46(1):51-5. PubMed ID: 10882688
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Telithromycin: the first ketolide antibacterial for the treatment of community-acquired respiratory tract infections.
    Lorenz J
    Int J Clin Pract; 2003; 57(6):519-29. PubMed ID: 12918892
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro activity of ketolides HMR 3004 and HMR 3647 and seven other antimicrobial agents against Corynebacterium diphtheriae.
    Engler KH; Warner M; George RC
    J Antimicrob Chemother; 2001 Jan; 47(1):27-31. PubMed ID: 11152428
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Macrolides and ketolides: azithromycin, clarithromycin, telithromycin.
    Zuckerman JM
    Infect Dis Clin North Am; 2004 Sep; 18(3):621-49, xi-. PubMed ID: 15308279
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.